Add BrightSurf on Google Email

American Heart Association Comment: Abciximab In Patients With Refractory Unstable Angina In Relation To Serum Troponin T Levels

A recent study published in the New England Journal of Medicine found that abciximab, a blood-thinner, can help prevent heart attacks in patients with unstable angina who have high troponin T levels. The treatment reduced heart attack risk by 44% in these patients compared to those without elevated troponin T levels.

SourceAmerican Heart Association·JournalNew England Journal of Medicine·DateMay 27, 1999